News
PhD student awarded for research on pain-relieving effects of CBD
An American PhD candidate has won a prestigious award for his research on the effectiveness of CBD.
Martin De Vita, PhD candidate in psychology at Syracuse University in New York state has received the university’s research excellence award for his study on the pain-relieving effects of cannabidiol (CBD) in humans.
De Vita received the Federation of Associations in Behavioral and Brain Sciences (FABBS) Doctoral Dissertation Research Excellence Award for his dissertation, The effects of cannabidiol and analgesic expectancies on experimental pain reactivity in healthy adults: A balanced placebo design trial.
His study looked at whether the pain relief CBD users claim to experience is due to pharmacological effects or placebo.
De Vita’s research team found that CBD and expectancies for receiving CBD do not appear to reduce experimental pain intensity, but do make the pain feel less unpleasant.
As part of the study De Vita developed advanced experimental pain measurement protocols.
“There are these other dimensions of pain, and it would be interesting to see which ones are being targeted,” De Vita said at the time.
Martin De Vita
“We found that sometimes pharmacological effects of CBD brought down some of those, but the expectancies did not. Sometimes they both did it. Sometimes it was just the expectancy. And so, we were going into this thinking we were going to primarily detect the expectancy-induced pain relief but what we found out was way more complex than that and that’s exciting.”
The FABBS Doctoral Dissertation Research Excellence Awards acknowledges and honours graduate student scientists who have conducted doctoral dissertation research of superior scientific quality and broader societal impact.
De Vita’s study garnered national media attention, being featured in outlets including Yahoo! and Medical News Today.
-
Health3 months agoCannabis linked to ‘substantial improvements’ in endometriosis symptoms
-
News4 months agoGrounding of British Airways flight sparks calls for more medical cannabis education
-
Industry4 months agoThe tipping point? UK cannabis clinics urged to clean up ‘concerning’ prescribing practices
-
Industry6 months agoLyphe UK to Launch Noidecs Vital, a New Low-Cost Medical Cannabis Line
-
News5 months agoA new centre-left government and the potential for ‘change’ in the UK cannabis landscape
-
Science5 months agoCBG found to reduce anxiety and enhance memory in clinical trial
-
Health6 months agoNew UK study highlights scale of illegal cannabis use for health reasons
-
Epilepsy2 months ago
UCL Launches 2 Medical Cannabis Trials Into Childhood Epilepsy, but Experts Warn It Is Not the Solution Many Have Been Waiting For
